Why the study?
Despite early myocardial revascularization by PPCI for STEMI, a proportion of patients still have impaired cardiac function and increased cardiovascular mortality.
Key points are not available for this paper at this time.
Population
Patients with STEMI
Comparison
Nicorandil prior to PPCI vs control
Design
Meta-analysis of randomized controlled trials
Answers are grounded in this paper and cite their sources.
Supports nicorandil pre-treatment before primary PCI in STEMI; extends RCT evidence to pooled clinical and functional benefits.
Early myocardial revascularization by the primary percutaneous coronary intervention (PPCI) was an important treatment for patients with ST-segment elevated myocardial infarction (STEMI); thus, a proportion of STEMI subjects still have impaired cardiac function and increased cardiovascular mortality.
No takes yet. Share an insight, caveat, or question.
Li et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: